Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7070)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Noble F, Nolan L, Bateman AC, Byrne JP, Kelly JJ, Bailey IS, Sharland DM, Rees CN, Iveson TJ, Underwood TJ, Bateman AR. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J Gastroenterol 2013; 19(48): 9282-9293 [PMID: 24409055 DOI: 10.3748/wjg.v19.i48.9282] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9282.htm |
| Number | Citing Articles |
| 1 |
Fergus Noble, Toby Mellows, Leo H. McCormick Matthews, Adrian C. Bateman, Scott Harris, Timothy J. Underwood, James P. Byrne, Ian S. Bailey, Donna M. Sharland, Jamie J. Kelly, John N. Primrose, Surinder S. Sahota, Andrew R. Bateman, Gareth J. Thomas, Christian H. Ottensmeier. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunology, Immunotherapy 2016; 65(6): 651 doi: 10.1007/s00262-016-1826-5
|
| 2 |
Shinichi Okazumi, Gaku Ohira, Koichi Hayano, Tomoyoshi Aoyagi, Shunsuke Imanishi, Hisahiro Matsubara. Novel Advances in Qualitative Diagnostic Imaging for Decision Making in Multidisciplinary Treatment for Advanced Esophageal Cancer. Journal of Clinical Medicine 2024; 13(2): 632 doi: 10.3390/jcm13020632
|
| 3 |
Ning Li, Zhi Li, Qiang Fu, Bin Zhang, Jian Zhang, Xiang-Bin Wan, Chao-Min Lu, Jin-Bang Wang, Wen-Ying Deng, Yi-Jie Ma, Liang-Yu Bie, Meng-Yu Wang, Jing Li, Qing-Xin Xia, Chen Wei, Su-Xia Luo. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study. International Journal of Surgery 2024; 110(4): 2071 doi: 10.1097/JS9.0000000000001119
|
| 4 |
Jaine K. Blayney, Lauren Cairns, Gerald Li, Niamh McCabe, Leanne Stevenson, Christopher J. Peters, Nathan B. Reid, Veronica J. Spence, Chintapuza Chisambo, Damian McManus, Jacqueline James, Stephen McQuaid, Stephanie Craig, Kenneth Arthur, Darragh McArt, Chin-Ann
J. Ong, Pierre Lao-Sirieix, Peter Hamilton, Manuel Salto-Tellez, Martin Eatock, Helen G. Coleman, Rebecca C. Fitzgerald, Richard D. Kennedy, Richard C. Turkington. Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma. Oncotarget 2018; 9(26): 18518 doi: 10.18632/oncotarget.24906
|
| 5 |
Abdelkader Taibi, Rea Lo Dico, Rachid Kaci, Anne Laure Naneix, Muriel Mathonnet, Marc Pocard. Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG. Surgical Oncology 2020; 33: 158 doi: 10.1016/j.suronc.2020.02.014
|
| 6 |
William R. C. Knight, Cara R. Baker, Nyree Griffin, Wahyu Wulaningsih, Mark Kelly, Andrew R. Davies, James A. Gossage, O. Hynes, G. Tham, C. Iezzi, R. Bott, N. Maisey, A. Gaya, S. Ngan, A. Qureshi, M. Green, A. Jacques, V. Goh, H. Deere, F. Chang, U. Mahadeva, B. Gill-Barman, S. George, J. Dunn, S. Zeki, J. Meenan. Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?. British Journal of Cancer 2021; 124(10): 1653 doi: 10.1038/s41416-021-01290-4
|
| 7 |
Yushi Nagaki, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Hiromu Fujita, Yoshihiro Sasaki, Kazuhiro Imai, Yoshihiro Minamiya. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08918-x
|
| 8 |
Ankur K Patel, Xueliang Pan, Diana M Vila, Wendy L Frankel, Wei Chen, Kyle A Perry, Robert E Merritt, Desmond M D'Souza, Evan J Wuthrick, Terence M Williams. Perineural invasion predicts for locoregional failure in patients with oesophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy. Journal of Clinical Pathology 2021; 74(4): 228 doi: 10.1136/jclinpath-2020-206424
|
| 9 |
Jonathan L. Moore, Michael Green, Aida Santaolalla, Harriet Deere, Richard P.T. Evans, Mona Elshafie, Anita Lavery, Damian T. McManus, Andrew McGuigan, Rosalie Douglas, Joanne Horne, Robert Walker, Hira Mir, Monica Terlizzo, Sivesh K. Kamarajah, Mieke Van Hemelrijck, Nick Maisey, Ailsa Sita-Lumsden, Sarah Ngan, Mark Kelly, Cara R. Baker, Sacheen Kumar, Jesper Lagergren, William H. Allum, James A. Gossage, Ewen A. Griffiths, Heike I. Grabsch, Richard C. Turkington, Tim J. Underwood, Elizabeth C. Smyth, Rebecca C. Fitzgerald, David Cunningham, Andrew R. Davies, S. Puig, A. Chaudry, A. Jacques, N. Griffin, V. Goh, K. Owczarczyk, A Qureshi, M. Subesinghe, F. Chang, U. Mahadeva, B. Gill-Barman, S. George, M. Ong, J. Waters, M. Cominos, T. Sevitt, M. Hill, O. Hynes, G. Tham, W R C Knight, J. M. Dunn, S. S. Zeki. Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom. Journal of Clinical Oncology 2023; 41(28): 4522 doi: 10.1200/JCO.23.00139
|
| 10 |
Pinar Atasoy, Sibel Sensu. Risk Factors and Therapy of Esophagus Cancer. 2024; : 583 doi: 10.1007/978-3-031-47024-0_37
|
| 11 |
David M. Bunting, Wesley W. Lai, Richard G. Berrisford, Tim J. Wheatley, Brent Drake, Grant Sanders. Positron Emission Tomography–Computed Tomography in Oesophageal Cancer Staging: A Tailored Approach. World Journal of Surgery 2015; 39(4): 1000 doi: 10.1007/s00268-014-2892-5
|
| 12 |
D. J. Crull, M. C. H. Hogenes, R. Hoekstra, E. M. Hendriksen, M. J. van Det, E. A. Kouwenhoven. The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma. Annals of Surgical Oncology 2022; 29(6): 3658 doi: 10.1245/s10434-022-11336-3
|
| 13 |
Kei Hosoda, Keishi Yamashita, Harukazu Tsuruta, Hiromitsu Moriya, Hiroaki Mieno, Akira Ema, Marie Washio, Masahiko Watanabe. Prognoses of advanced esophago‑gastric junction cancer may be modified by thoracotomy and splenectomy. Oncology Letters 2017; doi: 10.3892/ol.2017.7441
|
| 14 |
Alfred K. Lam, Michael J. Bourke, Renyin Chen, Roberto Fiocca, Fumiyoshi Fujishima, Satoshi Fujii, Marnix Jansen, Priyanthi Kumarasinghe, Rupert Langer, Simon Law, Sybren L. Meijer, Cian Muldoon, Marco Novelli, Chanjuan Shi, Laura Tang, Iris D. Nagtegaal. Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting. Human Pathology 2021; 114: 54 doi: 10.1016/j.humpath.2021.05.003
|
| 15 |
Han Tang, Lijie Tan, Hao Wang, Yaxing Shen, Jun Yin. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved. Journal of Gastrointestinal Surgery 2020; 24(7): 1469 doi: 10.1007/s11605-019-04317-7
|
| 16 |
Ken Hatogai, Satoshi Fujii, Takashi Kojima, Hiroyuki Daiko, Tomohiro Kadota, Takeo Fujita, Takayuki Yoshino, Toshihiko Doi, Yuichi Takiguchi, Atsushi Ohtsu. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. Journal of Surgical Oncology 2016; 113(4): 390 doi: 10.1002/jso.24151
|
| 17 |
G. Tomasello, F. Petrelli, M. Ghidini, E. Pezzica, R. Passalacqua, F. Steccanella, L. Turati, G. Sgroi, S. Barni. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies. European Journal of Surgical Oncology 2017; 43(9): 1607 doi: 10.1016/j.ejso.2017.03.001
|
| 18 |
F Noble, M A Lloyd, R Turkington, E Griffiths, M O'Donovan, J R O'Neill, S Mercer, S L Parsons, R C Fitzgerald, T J Underwood, A Noorani, R Fels Elliott, Z Abdullahi, R de la Rue, J Bornschein, S MacRae, B Nutzinger, N Grehan, G Contino, J Crawte, P A W Edwards, A Miremadi, S Malhotra, A Hayden, R Walker, C Peters, G Hannah, R Hardwick, J Davies, H Ford, D Gilligan, P Safranek, A Hindmarsh, V Sujendran, N Carroll, D McManus, S J Hayes, Y Ang, S R Preston, S Oakes, I Bagwan, R J E Skipworth, V Save, T R Hupp, S Puig, M Bedford, P Taniere, J Whiting, J Byrne, J Kelly, J Owsley, C Crichton, H Barr, N Shepherd, O Old, J Lagergren, J Gossage, A Davies, F Chang, J Zylstra, G Sanders, R Berrisford, C Harden, D Bunting, M Lewis, E Cheong, B Kumar, J H Saunders, I N Soomro, R Vohra, J Duffy, P Kaye, A Grabowska, L Lovat, R Haidry, V Eneh, L Igali, I Welch, M Scott, S Sothi, S Suortamo, S Lishman, D Beardsmore, R Sutaria, M Secrier, M D Eldridge, L Bower, A G Lynch, S Tavaré. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. British Journal of Surgery 2017; 104(13): 1816 doi: 10.1002/bjs.10627
|
| 19 |
Y.-K. Chao, W.-Y. Chuang, H.-K. Chang, C.-K. Tseng, C.-J. Yeh, Y.-H. Liu. Prognosis of patients with esophageal squamous cell carcinoma who achieve major histopathological response after neoadjuvant chemoradiotherapy. European Journal of Surgical Oncology (EJSO) 2017; 43(1): 234 doi: 10.1016/j.ejso.2016.05.036
|
| 20 |
Noel E. Donlon, Andrew Sheppard, Maria Davern, Fiona O’Connell, James J. Phelan, Robert Power, Timothy Nugent, Kate Dinneen, John Aird, John Greene, Paul Nevins Selvadurai, Anshul Bhardwaj, Emma K. Foley, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght, Jacintha O’Sullivan, Margaret R. Dunne. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines. Cancers 2020; 12(11): 3356 doi: 10.3390/cancers12113356
|
| 21 |
Chris Harrington, Lyn Smith, Jennifer Bisland, Elisabet López González, Neil Jamieson, Stuart Paterson, Adrian John Stanley. Mediastinal node staging by positron emission tomography-computed tomography and selective endoscopic ultrasound with fine needle aspiration for patients with upper gastrointestinal cancer: Results from a regional centre. World Journal of Gastrointestinal Endoscopy 2018; 10(1): 37-44 doi: 10.4253/wjge.v10.i1.37
|
| 22 |
L H McCormick Matthews, F Noble, J Tod, E Jaynes, S Harris, J N Primrose, C Ottensmeier, G J Thomas, T J Underwood. Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma. British Journal of Cancer 2015; 113(1): 107 doi: 10.1038/bjc.2015.179
|
| 23 |
Noel E. Donlon, Maria Davern, Andrew Sheppard, Robert Power, Fiona O’Connell, Aisling B. Heeran, Ross King, Conall Hayes, Anshul Bhardwaj, James J. Phelan, Margaret R. Dunne, Narayanasamy Ravi, Claire L. Donohoe, Jacintha O’Sullivan, John V. Reynolds, Joanne Lysaght. The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling. Cancers 2021; 13(16): 4005 doi: 10.3390/cancers13164005
|
| 24 |
F J C ten Kate, S H van Olphen, M J Bruno, B P L Wijnhoven, J J B van Lanschot, L H J Looijenga, R C Fitzgerald, K Biermann. Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma. British Journal of Surgery 2017; 104(10): 1327 doi: 10.1002/bjs.10553
|
| 25 |
Gregory Tiesi, Wungki Park, Meredith Gunder, Gustavo Rubio, Michael Berger, Bach Ardalan, Alan Livingstone, Dido Franceschi. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer. Journal of Surgical Research 2017; 216: 65 doi: 10.1016/j.jss.2017.03.022
|
| 26 |
John H. Saunders, Christopher R. Bowman, Alex M. Reece‐Smith, Vincent Pang, Matthew S. Dorrington, Errum Mumtaz, Irshad Soomro, Philip Kaye, Srinivasan Madhusudan, Simon L. Parsons. The role of adjuvant platinum‐based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery. Journal of Surgical Oncology 2017; 115(7): 821 doi: 10.1002/jso.24601
|
| 27 |
David Bunting, Richard Berrisford, Tim Wheatley, Lee Humphreys, Arun Ariyarathenam, Grant Sanders. Prospective cohort study of neoadjuvant therapy toxicity in the treatment of oesophageal adenocarcinoma. International Journal of Surgery 2018; 52: 126 doi: 10.1016/j.ijsu.2018.02.023
|
| 28 |
Xingxing Wang, Hao Wang, Haixing Wang, Jie Huang, Xin Wang, Zhengzeng Jiang, Lijie Tan, Dongxian Jiang, Yingyong Hou. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07779-0
|
| 29 |
Hollie A. Clements, Tim J. Underwood, Russell D. Petty. Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma. British Journal of Cancer 2024; 130(1): 9 doi: 10.1038/s41416-023-02458-w
|
| 30 |
Nasser Davarzani, Gordon G A Hutchins, Nicholas P West, Lindsay C Hewitt, Matthew Nankivell, David Cunningham, William H Allum, Elizabeth Smyth, Nicola Valeri, Ruth E Langley, Heike I Grabsch. Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial. Histopathology 2018; 72(7): 1180 doi: 10.1111/his.13491
|
| 31 |
Yilin Tong, Dong Liu, Jianjun Zhang. Connection and distinction of tumor regression grading systems of gastrointestinal cancer. Pathology - Research and Practice 2020; 216(9): 153073 doi: 10.1016/j.prp.2020.153073
|
| 32 |
Chien-Hung Chiu, W-H. Chen, Y-W. Wen, C-J. Yeh, Y-K. Chao, H-K. Chang, C-K. Tseng, Y-H. Liu. Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy. Diseases of the Esophagus 2016; 29(6): 634 doi: 10.1111/dote.12388
|
| 33 |
K.G. Foley, A. Christian, P. Fielding, W.G. Lewis, S.A. Roberts. Accuracy of contemporary oesophageal cancer lymph node staging with radiological-pathological correlation. Clinical Radiology 2017; 72(8): 693.e1 doi: 10.1016/j.crad.2017.02.022
|
| 34 |
Andrew Cowie, Fergus Noble, Timothy Underwood. Strategies to improve outcomes in esophageal adenocarcinoma. Expert Review of Anticancer Therapy 2014; 14(6): 677 doi: 10.1586/14737140.2014.895668
|
| 35 |
Bing Liang, Hui Zhao, Jian-Bo Che, Hao-Jie Wang, Gong-Ning Shi. Overexpression of interleukin-8 receptor 2 (IL-8R2) indicates better prognosis in esophageal adenocarcinoma and squamous cell carcinoma procession. Medical Oncology 2014; 31(8) doi: 10.1007/s12032-014-0089-2
|
| 36 |
Andrea Zanoni, Giuseppe Verlato, Simone Giacopuzzi, Massimiliano Motton, Francesco Casella, Jacopo Weindelmayer, Elena Ambrosi, Alberto Di Leo, Antonios Vassiliadis, Francesco Ricci, Thomas W. Rice, Giovanni de Manzoni. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer. Annals of Surgical Oncology 2016; 23(S5): 998 doi: 10.1245/s10434-016-5440-8
|
| 37 |
A R Davies, D Myoteri, J Zylstra, C R Baker, W Wulaningsih, M Van Hemelrijck, N Maisey, W H Allum, E Smyth, J A Gossage, J Lagergren, D Cunningham, M Green, M Kelly, S Ngan, A Qureshi, A Gaya, N Griffin, A Jacques, V Goh, H Deere, F Chang, U Mahadeva, B Gill-Barman, S George, J Dunn, S Zeki, J Meenan, O Hynes, G Tham, C Iezzi, D Dellaportas, A Cowie, W Knight, N Valeri. Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma. British Journal of Surgery 2018; 105(12): 1639 doi: 10.1002/bjs.10900
|
| 38 |
J. Robert O’Neill, Ewan D. Kennedy, Vicki Save, Barbara Langdale-Brown, Lucy Wall, Richard J.E. Skipworth, Simon Paterson-Brown. Patients unfit for neoadjuvant therapy may still undergo resection of locally advanced esophageal or esophagogastric junctional cancer with acceptable oncological results. International Journal of Surgery Oncology 2017; 2(2): e09 doi: 10.1097/IJ9.0000000000000009
|
| 39 |
S. Gwynne, B.P.L. Wijnhoven, M. Hulshof, A. Bateman. Role of Chemoradiotherapy in Oesophageal Cancer — Adjuvant and Neoadjuvant Therapy. Clinical Oncology 2014; 26(9): 522 doi: 10.1016/j.clon.2014.05.015
|
| 40 |
Alfred K. Lam. Esophageal Adenocarcinoma. Methods in Molecular Biology 2018; 1756: 67 doi: 10.1007/978-1-4939-7734-5_6
|
| 41 |
Edwin Garcia, Annette Hayden, Charles Birts, Edward Britton, Andrew Cowie, Karen Pickard, Massimiliano Mellone, Clarisa Choh, Mathieu Derouet, Patrick Duriez, Fergus Noble, Michael J. White, John N. Primrose, Jonathan C. Strefford, Matthew Rose-Zerilli, Gareth J. Thomas, Yeng Ang, Andrew D. Sharrocks, Rebecca C. Fitzgerald, Timothy J. Underwood, Shona MacRae, Nicola Grehan, Zarah Abdullahi, Rachel de la Rue, Ayesha Noorani, Rachael Fels Elliott, Nadeera de Silva, Jan Bornschein, Maria O’Donovan, Gianmarco Contino, Tsun-Po Yang, Hamza Chettouh, Jason Crawte, Barbara Nutzinger, Paul A. W. Edwards, Laura Smith, Ahmad Miremadi, Shalini Malhotra, Alison Cluroe, Richard Hardwick, Jim Davies, Hugo Ford, David Gilligan, Peter Safranek, Andy Hindmarsh, Vijayendran Sujendran, Nick Carroll, Richard Turkington, Stephen J. Hayes, Yeng Ang, Shaun R. Preston, Sarah Oakes, Izhar Bagwan, Vicki Save, Richard J. E. Skipworth, Ted R. Hupp, J. Robert O’Neill, Olga Tucker, Philippe Taniere, Jack Owsley, Charles Crichton, Christian Schusterreiter, Hugh Barr, Neil Shepherd, Oliver Old, Jesper Lagergren, James Gossage, Andrew Davies, Fuju Chang, Janine Zylstra, Grant Sanders, Richard Berrisford, Catherine Harden, David Bunting, Mike Lewis, Ed Cheong, Bhaskar Kumar, Simon L. Parsons, Irshad Soomro, Philip Kaye, John Saunders, Laurence Lovat, Rehan Haidry, Victor Eneh, Laszlo Igali, Ian Welch, Michael Scott, Shamila Sothi, Sari Suortamo, Suzy Lishman, Duncan Beardsmore, Charlotte Anderson, Mike L. Smith, Maria Secrier, Matthew D. Eldridge, Lawrence Bower, Achilleas Achilleos, Andy G. Lynch, Simon Tavare. Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1. Scientific Reports 2016; 6(1) doi: 10.1038/srep32417
|